{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T05:26:27Z","timestamp":1784093187140,"version":"3.55.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,5,3]],"date-time":"2013-05-03T00:00:00Z","timestamp":1367539200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1186\/1471-2407-13-223","type":"journal-article","created":{"date-parts":[[2013,5,3]],"date-time":"2013-05-03T11:03:47Z","timestamp":1367579027000},"source":"Crossref","is-referenced-by-count":35,"title":["High CRP values predict poor survival in patients with penile cancer"],"prefix":"10.1186","volume":"13","author":[{"given":"Sandra","family":"Steffens","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Al Ghazal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Steinestel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rieke","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Wegener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J","family":"Schnoeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus V","family":"Cronauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Jentzmik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Schrader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus A","family":"Kuczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres J","family":"Schrader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,5,3]]},"reference":[{"key":"3851_CR1","volume-title":"Cancer incidences in five continents, vol. VIII, 155 edn","author":"DM Parkin","year":"2002","unstructured":"Parkin DM, Whelan SL, Ferlay J, Teppo L, Thomas DB: Cancer incidences in five continents, vol. VIII, 155 edn. 2002, Lyon, France: IARC Scientific Publications"},{"issue":"6","key":"3851_CR2","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1016\/j.eururo.2010.01.039","volume":"57","author":"G Pizzocaro","year":"2010","unstructured":"Pizzocaro G, Algaba F, Horenblas S, Solsona E, Tana S, Van Der Poel H, Watkin NA: EAU penile cancer guidelines 2009. Eur Urol. 2010, 57 (6): 1002-1012. 10.1016\/j.eururo.2010.01.039.","journal-title":"Eur Urol"},{"issue":"5","key":"3851_CR3","doi-asserted-by":"publisher","first-page":"2019","DOI":"10.1016\/j.juro.2008.07.040","volume":"180","author":"Y Zhu","year":"2008","unstructured":"Zhu Y, Ye DW, Yao XD, Zhang SL, Dai B, Zhang HL, Shen YJ: The value of squamous cell carcinoma antigen in the prognostic evaluation, treatment monitoring and followup of patients with penile cancer. J Urol. 2008, 180 (5): 2019-2023. 10.1016\/j.juro.2008.07.040.","journal-title":"J Urol"},{"issue":"1","key":"3851_CR4","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1111\/j.1464-410X.2007.06908.x","volume":"100","author":"Y Zhu","year":"2007","unstructured":"Zhu Y, Zhou XY, Yao XD, Dai B, Ye DW: The prognostic significance of p53, Ki-67, epithelial cadherin and matrix metalloproteinase-9 in penile squamous cell carcinoma treated with surgery. BJU Int. 2007, 100 (1): 204-208. 10.1111\/j.1464-410X.2007.06908.x.","journal-title":"BJU Int"},{"issue":"9","key":"3851_CR5","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1136\/jech.2006.051292","volume":"61","author":"K Heikkila","year":"2007","unstructured":"Heikkila K, Ebrahim S, Lawlor DA: A systematic review of the association between circulating concentrations of C reactive protein and cancer. J Epidemiol Community Health. 2007, 61 (9): 824-833. 10.1136\/jech.2006.051292.","journal-title":"J Epidemiol Community Health"},{"issue":"2","key":"3851_CR6","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1749-4486.2011.02274.x","volume":"36","author":"HH Chen","year":"2011","unstructured":"Chen HH, Chen IH, Liao CT, Wei FC, Lee LY, Huang SF: Preoperative circulating C-reactive protein levels predict pathological aggressiveness in oral squamous cell carcinoma: a retrospective clinical study. Clin Otolaryngol. 2011, 36 (2): 147-153. 10.1111\/j.1749-4486.2011.02274.x.","journal-title":"Clin Otolaryngol"},{"key":"3851_CR7","first-page":"22","volume":"2012","author":"S Motoyama","year":"2012","unstructured":"Motoyama S, Nakatsu T, Miura M, Hinai Y, Minamiya Y, Ogawa JI: A CRP genetic polymorphism associated with the tumoral expression of CRP in esophageal cancer. Surg Today. 2012, 2012: 22-","journal-title":"Surg Today"},{"issue":"7","key":"3851_CR8","doi-asserted-by":"publisher","first-page":"652","DOI":"10.1007\/s00595-012-0147-3","volume":"42","author":"T Nakatsu","year":"2012","unstructured":"Nakatsu T, Motoyama S, Maruyama K, Usami S, Sato Y, Miura M, Hinai Y, Saito H, Minamiya Y, Murata K: Tumoral CRP expression in thoracic esophageal squamous cell cancers is associated with poor outcomes. Surg Today. 2012, 42 (7): 652-658. 10.1007\/s00595-012-0147-3.","journal-title":"Surg Today"},{"issue":"Suppl 2(95","key":"3851_CR9","first-page":"S199","volume":"95","author":"V Srimuninnimit","year":"2012","unstructured":"Srimuninnimit V, Ariyapanya S, Nimmannit A, Wonglaksanapimon S, Akewanlop C, Soparattanapaisarn N: C-reactive protein as a monitor of chemotherapy response in advanced non-small cell lung cancer (CML study). J Med Assoc Thai. 2012, 95 (Suppl 2(95): S199-207.","journal-title":"J Med Assoc Thai"},{"issue":"1","key":"3851_CR10","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3349\/ymj.2012.53.1.111","volume":"53","author":"S Hong","year":"2012","unstructured":"Hong S, Kang YA, Cho BC, Kim DJ: Elevated serum C-reactive protein as a prognostic marker in small cell lung cancer. Yonsei Med J. 2012, 53 (1): 111-117. 10.3349\/ymj.2012.53.1.111.","journal-title":"Yonsei Med J"},{"issue":"4","key":"3851_CR11","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1080\/00015458.2011.11680740","volume":"111","author":"H Neuss","year":"2011","unstructured":"Neuss H, Koplin G, Raue W, Reetz C, Mall JW: Analysing the serum levels of tumour markers and primary tumour data in stage III melanoma patients in correlation to the extent of lymph node metastases\u2013a prospective study in 231 patients. Acta Chir Belg. 2011, 111 (4): 214-218.","journal-title":"Acta Chir Belg"},{"issue":"4","key":"3851_CR12","doi-asserted-by":"publisher","first-page":"2800","DOI":"10.1007\/s12032-012-0220-1","volume":"29","author":"A Kinoshita","year":"2012","unstructured":"Kinoshita A, Onoda H, Takano K, Imai N, Saeki C, Fushiya N, Miyakawa Y, Nishino H, Tajiri H: Pretreatment serum C-reactive protein level predicts poor prognosis in patients with hepatocellular carcinoma. Med Oncol. 2012, 29 (4): 2800-2808. 10.1007\/s12032-012-0220-1.","journal-title":"Med Oncol"},{"issue":"7","key":"3851_CR13","first-page":"26057","volume":"2012","author":"W Sieghart","year":"2012","unstructured":"Sieghart W, Pinter M, Hucke F, Graziadei I, Schoniger-Hekele M, Muller C, Vogel W, Trauner M, Peck-Radosavljevic M: A single determination of C-reactive protein at the time of diagnosis predicts long term outcome of patients with hepatocellular carcinoma. Hepatology. 2012, 2012 (7): 26057-","journal-title":"Hepatology"},{"issue":"4","key":"3851_CR14","doi-asserted-by":"crossref","first-page":"209","DOI":"10.5301\/JBM.2011.8872","volume":"26","author":"Y Han","year":"2011","unstructured":"Han Y, Mao F, Wu Y, Fu X, Zhu X, Zhou S, Zhang W, Sun Q, Zhao Y: Prognostic role of C-reactive protein in breast cancer: a systematic review and meta-analysis. Int J Biol Markers. 2011, 26 (4): 209-215.","journal-title":"Int J Biol Markers"},{"issue":"41","key":"3851_CR15","first-page":"2927","volume":"91","author":"LJ Wang","year":"2012","unstructured":"Wang LJ, Zhou H, Lu HW, Li J, Lin ZQ: Prognostic value of preoperative serum high sensitivity C-reactive protein in patients with endometrial cancer. Zhonghua Yi Xue Za Zhi. 2012, 91 (41): 2927-2930.","journal-title":"Zhonghua Yi Xue Za Zhi"},{"issue":"1","key":"3851_CR16","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1186\/1471-2407-12-399","volume":"12","author":"S Steffens","year":"2012","unstructured":"Steffens S, Kohler A, Rudolph R, Eggers H, Seidel C, Janssen M, Wegener G, Schrader M, Kuczyk MA, Schrader AJ: Validation of CRP as prognostic marker for renal cell carcinoma in a large series of patients. BMC Cancer. 2012, 12 (1): 399-10.1186\/1471-2407-12-399.","journal-title":"BMC Cancer"},{"issue":"7","key":"3851_CR17","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1038\/bjc.2012.360","volume":"107","author":"SH Sim","year":"2012","unstructured":"Sim SH, Messenger MP, Gregory WM, Wind TC, Vasudev NS, Cartledge J, Thompson D, Selby PJ, Banks RE: Prognostic utility of pre-operative circulating osteopontin, carbonic anhydrase IX and CRP in renal cell carcinoma. Br J Cancer. 2012, 107 (7): 1131-1137. 10.1038\/bjc.2012.360.","journal-title":"Br J Cancer"},{"issue":"10","key":"3851_CR18","doi-asserted-by":"publisher","first-page":"1478","DOI":"10.1111\/j.1464-410X.2012.11153.x","volume":"2012","author":"K Saito","year":"2012","unstructured":"Saito K, Urakami S, Komai Y, Yasuda Y, Kubo Y, Kitsukawa S, Okubo Y, Yamamoto S, Yonese J, Fukui I: Impact of C-reactive protein kinetics on survival of patients with advanced urothelial carcinoma treated by second-line chemotherapy with gemcitabine, etoposide and cisplatin. BJU Int. 2012, 2012 (10): 1478-1484.","journal-title":"BJU Int"},{"issue":"5","key":"3851_CR19","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.urology.2011.07.1416","volume":"78","author":"M Ito","year":"2011","unstructured":"Ito M, Saito K, Yasuda Y, Sukegawa G, Kubo Y, Numao N, Kitsukawa S, Urakami S, Yuasa T, Yamamoto S: Prognostic impact of C-reactive protein for determining overall survival of patients with castration-resistant prostate cancer treated with docetaxel. Urology. 2011, 78 (5): 1131-1135. 10.1016\/j.urology.2011.07.1416.","journal-title":"Urology"},{"issue":"4","key":"3851_CR20","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1007\/s13277-012-0337-z","volume":"33","author":"Y Cao","year":"2012","unstructured":"Cao Y, Shi YX, Chen JO, Tan YT, Cai YC, Luo HY, Qiu MZ, Cai XY, Jin Y, Sun YL: Serum C-reactive protein as an important prognostic variable in patients with diffuse large B cell lymphoma. Tumour Biol. 2012, 33 (4): 1039-1044. 10.1007\/s13277-012-0337-z.","journal-title":"Tumour Biol"},{"issue":"4","key":"3851_CR21","first-page":"1409","volume":"32","author":"M Ishizuka","year":"2012","unstructured":"Ishizuka M, Nagata H, Takagi K, Kubota K: C-reactive protein is associated with distant metastasis of T3 colorectal cancer. Anticancer Res. 2012, 32 (4): 1409-1415.","journal-title":"Anticancer Res"},{"issue":"12","key":"3851_CR22","first-page":"00796","volume":"4804","author":"WS Lee","year":"2012","unstructured":"Lee WS, Baek JH, You DH, Nam MJ: Prognostic value of circulating cytokines for stage III colon cancer. J Surg Res. 2012, 4804 (12): 00796-00792.","journal-title":"J Surg Res"},{"issue":"12","key":"3851_CR23","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1172\/JCI200318921","volume":"111","author":"MB Pepys","year":"2003","unstructured":"Pepys MB, Hirschfield GM: C-reactive protein: a critical update. J Clin Invest. 2003, 111 (12): 1805-1812.","journal-title":"J Clin Invest"},{"issue":"13","key":"3851_CR24","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1200\/JCO.2008.19.8440","volume":"27","author":"KH Allin","year":"2009","unstructured":"Allin KH, Bojesen SE, Nordestgaard BG: Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer. J Clin Oncol. 2009, 27 (13): 2217-2224. 10.1200\/JCO.2008.19.8440.","journal-title":"J Clin Oncol"},{"issue":"4","key":"3851_CR25","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1158\/0008-5472.CAN-05-3631","volume":"66","author":"MJ Gunter","year":"2006","unstructured":"Gunter MJ, Stolzenberg-Solomon R, Cross AJ, Leitzmann MF, Weinstein S, Wood RJ, Virtamo J, Taylor PR, Albanes D, Sinha R: A prospective study of serum C-reactive protein and colorectal cancer risk in men. Cancer Res. 2006, 66 (4): 2483-2487. 10.1158\/0008-5472.CAN-05-3631.","journal-title":"Cancer Res"},{"issue":"4","key":"3851_CR26","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1158\/1055-9965.EPI-05-0708","volume":"15","author":"T Otani","year":"2006","unstructured":"Otani T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S: Plasma C-reactive protein and risk of colorectal cancer in a nested case-control study: Japan Public Health Center-based prospective study. Cancer Epidemiol Biomarkers Prev. 2006, 15 (4): 690-695. 10.1158\/1055-9965.EPI-05-0708.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"33","key":"3851_CR27","doi-asserted-by":"publisher","first-page":"5216","DOI":"10.1200\/JCO.2006.07.1381","volume":"24","author":"C Siemes","year":"2006","unstructured":"Siemes C, Visser LE, Coebergh JW, Splinter TA, Witteman JC, Uitterlinden AG, Hofman A, Pols HA, Stricker BH: C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study. J Clin Oncol. 2006, 24 (33): 5216-5222. 10.1200\/JCO.2006.07.1381.","journal-title":"J Clin Oncol"},{"issue":"12","key":"3851_CR28","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nrurol.2011.145","volume":"8","author":"K Saito","year":"2011","unstructured":"Saito K, Kihara K: C-reactive protein as a biomarker for urological cancers. Nat Rev Urol. 2011, 8 (12): 659-666.","journal-title":"Nat Rev Urol"},{"issue":"4","key":"3851_CR29","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3109\/10408363.2011.599831","volume":"48","author":"KH Allin","year":"2011","unstructured":"Allin KH, Nordestgaard BG: Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer. Crit Rev Clin Lab Sci. 2011, 48 (4): 155-170. 10.3109\/10408363.2011.599831.","journal-title":"Crit Rev Clin Lab Sci"},{"issue":"6","key":"3851_CR30","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1016\/j.humpath.2012.01.014","volume":"43","author":"A Chaux","year":"2012","unstructured":"Chaux A, Cubilla AL: Advances in the pathology of penile carcinomas. Hum Pathol. 2012, 43 (6): 771-789. 10.1016\/j.humpath.2012.01.014.","journal-title":"Hum Pathol"},{"key":"3851_CR31","first-page":"abstract #1661","volume":"e667","author":"TMV Johnson","year":"2011","unstructured":"Johnson TMV, Abbasi A, Kucuk O, Young A, Ogan K, Patteras J, Nieh P, Marshall F, Osunkoya A: Intratumoral C-reative proein as a biomarker of pronosis in localized ranl cell carcinoma. J Urol. 2011, e667: abstract #1661-","journal-title":"J Urol"},{"issue":"3","key":"3851_CR32","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1093\/jnci\/djp459","volume":"102","author":"KH Allin","year":"2010","unstructured":"Allin KH, Nordestgaard BG, Zacho J, Tybjaerg-Hansen A, Bojesen SE: C-reactive protein and the risk of cancer: a mendelian randomization study. J Natl Cancer Inst. 2010, 102 (3): 202-206. 10.1093\/jnci\/djp459.","journal-title":"J Natl Cancer Inst"}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-223.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2407-13-223\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2407-13-223","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,13]],"date-time":"2019-07-13T10:37:34Z","timestamp":1563014254000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/1471-2407-13-223"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,5,3]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["3851"],"URL":"https:\/\/doi.org\/10.1186\/1471-2407-13-223","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,5,3]]},"article-number":"223"}}